Clinical utility of ploidy/SPF in breast Ca's
Dahl-Chase Pathology (dahlchas@mint.net)
Thu, 11 Apr 1996 14:42:35 -0400
Hi everybody in clinical cytometry. I would like some input on the type of
cases which should be analyzed for ploidy/cell cycle analysis. We have read
the 1993 consensus review on breast carcinomas and found it helpful but
sometimes vague. What is the most recent consensus regarding the type of
breast carcinomas to be analyzed by flow. Should we do:
1. both node positive and node negative cases?
or 2. node negative invasive only?
or 3. If node negative only, which grades should be selected?
Are there any recent significant "key references" addressing these questions?
Right now, we are doing node negative invasive non-ductal breast ca, grades
I, II, and sometimes III.
Thank you for your input!
Andrea Illingworth - Dahl Chase Diagnostic Services
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories
and distributed free of charge as an educational service to the cytometry community.
If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL,
Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu
EMAIL robinson@flowcyt.cyto.purdue.edu
